1. Home
  2. FIVN vs BHVN Comparison

FIVN vs BHVN Comparison

Compare FIVN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five9 Inc.

FIVN

Five9 Inc.

HOLD

Current Price

$27.45

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.49

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVN
BHVN
Founded
2001
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
FIVN
BHVN
Price
$27.45
$13.49
Analyst Decision
Buy
Buy
Analyst Count
18
14
Target Price
$26.06
$29.08
AVG Volume (30 Days)
2.4M
2.1M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
364.71
26.08
EPS
0.21
N/A
Revenue
$1,149,088,000.00
N/A
Revenue This Year
$11.39
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
$132.40
N/A
Revenue Growth
10.28
N/A
52 Week Low
$13.29
$7.48
52 Week High
$28.86
$18.57

Technical Indicators

Market Signals
Indicator
FIVN
BHVN
Relative Strength Index (RSI) 63.52 43.50
Support Level $17.66 $9.42
Resistance Level N/A $14.01
Average True Range (ATR) 1.67 0.83
MACD 0.23 -0.33
Stochastic Oscillator 81.91 10.90

Price Performance

Historical Comparison
FIVN
BHVN

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: